Nuveen Corporate Income November 2021 Target Term Fund (JHB) Stock Overview
Explore Nuveen Corporate Income November 2021 Target Term Fund’s financial performance, market position, analyst ratings, and future outlook.
Nuveen Corporate Income November 2021 Target Term Fund (JHB)
Key Financials
Key Financials
Market Cap
0
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
JHB Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Nuveen Corporate Income November 2021 Target Term Fund (NYSE: JHB) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Nuveen Corporate Income November 2021 Target Term Fund's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of JHB on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $9.54 for the NYSE listing.
Key metrics behind Nuveen Corporate Income November 2021 Target Term Fund's NYSE-traded stock include a P/E ratio of N/A and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of JHB on the NYSE.